Skip to content

Ayurvedic intervention for stress in IT professionals

A randomized double blind placebo controlled clinical trial on Ayurvedic intervention in the management of Occupational stress among I T professionals - AYUSH-SR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020798
Enrollment
100
Registered
2019-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F438- Other reactions to severe stress

Interventions

Intervention1: AYUSH SR - A coded drug: 1. AYUSH - SR(In tablet form) Dose 500 mg X 2 tab b i d Dosage form Tablet Route of Administration Oral Time of Administration Twice a day after fo

Sponsors

CCRAS MINISTRY OF AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Software professionals with a work experience of more than one year 2. Subjects screened with OSI (Occupational Stress Index) (Manual of Occupational Stress Index, Dr. A. K Srivastava & Dr. A.P Singh (1982), Department of Psychology, BHU) and those who scored above 46 areincluded. 3. Subjects who are willing to participate in the clinical trial and signing the consent form. 4. Subjects in the age group 25 - 40 years irrespective of gender and socioeconomic status. 5. Subjects fulfilling the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from other psychiatric disorders and using anti psychiatric therapy 2. Subjects with history of Alcoholism and substance abuse 3. Patients with Hypothyroidism and Hyperthyroidism 4. Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2mg/dl), uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease. 5. Diabetic patients with HbA1c value above 8 6. Patients whose blood pressure systolic above 160 mm of Hg and diastolic more than 100 mm of Hg 7. Women who are planning to conceive, Pregnant or lactating woman. 8. H/o hypersensitivity to any of the trial drugs or their ingredients. 9. Patients who have completed participation in any other clinical trial during the past 3 months. 10. Any other condition which the investigator thinks may jeopardize the study.

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measure - Change in Occupational Stress Index (OSI) score Timepoint: 3 years - study duration 90 days - Intervention period

Secondary

MeasureTime frame
Secondary Outcome Measure - Changes in the scores of WHO Well- Being Index (1998 version) - Changes in the scores of ManasaBhavaPareeksha Timepoint: 3 years - study duration 90 days - Intervention period

Countries

India

Contacts

Public ContactG V RAMANA

CCRAS MINISTRY OF AYUSH

gvr1528@gmail.com9448346641

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026